Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway

International Journal of Oncology - Tập 48 Số 6 - Trang 2415-2424 - 2016
Tomoyuki Koguchi1, Chizu Tanikawa2, Jinichi Mori1, Yoshiyuki Kojima3, Koichi Matsuda1
1Laboratory of Clinical Sequence, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
2Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo, Tokyo, Japan
3Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Brady, 2010, p53 at a glance, J Cell Sci, 123, 2527, 10.1242/jcs.064501

Levine, 2009, The first 30 years of p53: Growing ever more complex, Nat Rev Cancer, 9, 749, 10.1038/nrc2723

Hirao, 2000, DNA damage-induced activation of p53 by the checkpoint kinase Chk2, Science, 287, 1824, 10.1126/science.287.5459.1824

Bensaad, 2006, TIGAR, a p53-inducible regulator of glycolysis and apoptosis, Cell, 126, 107, 10.1016/j.cell.2006.05.036

Hu, 2010, Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function, Proc Natl Acad Sci USA, 107, 7455, 10.1073/pnas.1001006107

Kenzelmann Broz, 2013, Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses, Genes Dev, 27, 1016, 10.1101/gad.212282.112

Ju, 2004, Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast, J Biol Chem, 279, 21759, 10.1074/jbc.M312078200

Croze, 2013, Potential role and therapeutic interests of myo-inositol in metabolic diseases, Biochimie, 95, 1811, 10.1016/j.biochi.2013.05.011

Maeba, 2008, Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome, J Nutr Sci Vitaminol (Tokyo), 54, 196, 10.3177/jnsv.54.196

Mukai, 2014, A meta-analysis of inositol for depression and anxiety disorders, Hum Psychopharmacol, 29, 55, 10.1002/hup.2369

Lam, 2006, A phase I study of myo-inositol for lung cancer chemoprevention, Cancer Epidemiol Biomarkers Prev, 15, 1526, 10.1158/1055-9965.EPI-06-0128

Han, 2009, The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers, Cancer Prev Res (Phila), 2, 370, 10.1158/1940-6207.CAPR-08-0209

Gustafson, 2010, Airway PI3K pathway activation is an early and reversible event in lung cancer development, Sci Transl Med, 2, 26ra25, 10.1126/scitranslmed.3000251

Oda, 2000, p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53, Cell, 102, 849, 10.1016/S0092-8674(00)00073-8

Tanikawa, 2003, p53RDL1 regulates p53-dependent apoptosis, Nat Cell Biol, 5, 216, 10.1038/ncb943

Tsukada, 1993, Enhanced proliferative potential in culture of cells from p53-deficient mice, Oncogene, 8, 3313

Taura, 2008, p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines, Mol Cell Biol, 28, 6557, 10.1128/MCB.01202-08

el-Deiry, 1992, Definition of a consensus binding site for p53, Nat Genet, 1, 45, 10.1038/ng0492-45

Michell, 2008, Inositol derivatives: Evolution and functions, Nat Rev Mol Cell Biol, 9, 151, 10.1038/nrm2334

Seelan, 2009, Identification of myo-inositol-3-phosphate synthase isoforms: Characterization, expression, and putative role of a 16-kDa gamma(c) isoform, J Biol Chem, 284, 9443, 10.1074/jbc.M900206200

Konarzewska, 2012, INO1 induction requires chromatin remodelers Ino80p and Snf2p but not the histone acetylases, Biochem Biophys Res Commun, 418, 483, 10.1016/j.bbrc.2012.01.044

Valluru, 2011, Myo-inositol and beyond - emerging networks under stress, Plant Sci, 181, 387, 10.1016/j.plantsci.2011.07.009

Deranieh, 2013, Phosphorylation regulates myo-inositol-3-phosphate synthase: A novel regulatory mechanism of inositol biosynthesis, J Biol Chem, 288, 26822, 10.1074/jbc.M113.479121

Parthasarathy, 2013, Rat brain myo-inositol 3-phosphate synthase is a phosphoprotein, Mol Cell Biochem, 378, 83, 10.1007/s11010-013-1597-7

Henry, 2014, The response to inositol: Regulation of glycerolipid metabolism and stress response signaling in yeast, Chem Phys Lipids, 180, 23, 10.1016/j.chemphyslip.2013.12.013

Guan, 2003, cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase, Arch Biochem Biophys, 417, 251, 10.1016/S0003-9861(03)00388-6

Chauvin, 2004, Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium, Biol Reprod, 70, 744, 10.1095/biolreprod.103.022731

Ye, 2013, PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma, Nat Commun, 4, 1508, 10.1038/ncomms2489

Ohnishi, 2014, Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis, J Biol Chem, 289, 10785, 10.1074/jbc.M113.536706

Eagle, 1957, Myo-inositol as an essential growth factor for normal and malignant human cells in tissue culture, J Biol Chem, 226, 191, 10.1016/S0021-9258(18)64820-3

Hecht, 2002, Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination, Carcinogenesis, 23, 1455, 10.1093/carcin/23.9.1455

Lee, 2005, Dietary administration of inositol and/or inositol-6-phosphate prevents chemically-induced rat hepatocarcinogenesis, Asian Pac J Cancer Prev, 6, 41

Nishino, 2009, Phytochemicals in hepatocellular cancer prevention, Nutr Cancer, 61, 789, 10.1080/01635580903285031

Vucenik, 2006, Protection against cancer by dietary IP6 and inositol, Nutr Cancer, 55, 109, 10.1207/s15327914nc5502_1

Wattenberg, 1996, Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methyl-nitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice, Cancer Res, 56, 5132

Witschi, 1999, Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone, Carcinogenesis, 20, 1375, 10.1093/carcin/20.7.1375

Kassie, 2010, Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice, Carcinogenesis, 31, 239, 10.1093/carcin/bgp174

Kassie, 2008, Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice, Cancer Prev Res (Phila), 1, 285, 10.1158/1940-6207.CAPR-08-0012

Memmott, 2010, The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis, Clin Cancer Res, 16, 4, 10.1158/1078-0432.CCR-09-0234

Kawase, 2009, PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt, Cell, 136, 535, 10.1016/j.cell.2008.12.002

Jacks, 1994, Tumor spectrum analysis in p53-mutant mice, Curr Biol, 4, 1, 10.1016/S0960-9822(00)00002-6